Cited by 1,539Metabolism, Diabetes, and CancerDiabetes, Cardiovascular Risks, and LipoproteinsDiet, Metabolism, and Disease

Mechanism of free fatty acid-induced insulin resistance in humans.

Open access
Roden, M, Price, T B, Perseghin, G, Petersen, K F, Rothman, D L, Cline, G W, Shulman, G I·1996·Journal of Clinical Investigation

Abstract

To examine the mechanism by which lipids cause insulin resistance in humans, skeletal muscle glycogen and glucose-6-phosphate concentrations were measured every 15 min by simultaneous 13C and 31P nuclear magnetic resonance spectroscopy in nine healthy subjects in the presence of low (0.18 +/- 0.02 mM [mean +/- SEM]; control) or high (1.93 +/- 0.04 mM; lipid infusion) plasma free fatty acid levels under euglycemic (approximately 5.2 mM) hyperinsulinemic (approximately 400 pM) clamp conditions for 6 h. During the initial 3.5 h of the clamp the rate of whole-body glucose uptake was not affected by lipid infusion, but it then decreased continuously to be approximately 46% of control values after 6 h (P < 0.00001). Augmented lipid oxidation was accompanied by a approximately 40% reduction of oxidative glucose metabolism starting during the third hour of lipid infusion (P < 0.05). Rates of muscle glycogen synthesis were similar during the first 3 h of lipid and control infusion, but thereafter decreased to approximately 50% of control values (4.0 +/- 1.0 vs. 9.3 +/- 1.6 mumol/[kg.min], P < 0.05). Reduction of muscle glycogen synthesis by elevated plasma free fatty acids was preceded by a fall of muscle glucose-6-phosphate concentrations starting at approximately 1.5 h (195 +/- 25 vs. control: 237 +/- 26 mM; P < 0.01). Therefore in contrast to the originally postulated mechanism in which free fatty acids were thought to inhibit insulin-stimulated glucose uptake in muscle through initial inhibition of pyruvate dehydrogenase these results demonstrate that free fatty acids induce insulin resistance in humans by initial inhibition of glucose transport/phosphorylation which is then followed by an approximately 50% reduction in both the rate of muscle glycogen synthesis and glucose oxidation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci118742

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Higher fasting glucose with low carbohydrate intake could be attributed to increased release of free fatty acids in response to a lower-carbohydrate diet, leading to worsening insulin resistance.

    “Higher fasting glucose with low carbohydrate intake could be attributed to the increased release of free fatty acids in response to a lower-carbohydrate diet, leading to worsening insulin resistance [78].”

    From Medical Nutrition Therapy for Women with Gestational Diabetes: Current Practice and Future Perspectives (2025) · cites this paper as [78]

    The Discussion concludes that elevated plasma free fatty acids cause insulin resistance, supporting the proposed final link. But the study raised fatty acids by lipid infusion during euglycemic clamps; it did not test whether a lower-carbohydrate diet increases fatty-acid release or raises fasting glucose. The Results report that plasma glucose was held constant during the clamps. (LLM, conf=0.90)

    Experimental — accuracy not yet measured
  • In vivo, infusion of lipid emulsions and heparin in healthy subjects increased plasma NEFA concentrations above the physiological range and was associated with development of insulin resistance mediated by changes in post-receptor insulin signalling.

    “In vivo, infusion of lipid emulsions and heparin in healthy subjects increased plasma NEFA concentrations to above the physiological range and were associated with the development of insulin resistance, an effect mediated by changes in post-receptor insulin signalling [149, 150, 151].”
  • Acute rises in circulating NEFA in healthy people cause or are linked to insulin resistance.

    “Acute elevation in circulating NEFA levels in healthy individuals has been linked to insulin resistance in multiple investigations [10–13].”

    From Sleep restriction increases free fatty acids in healthy men (2015) · cites this paper as [11]

  • In healthy individuals, high plasma fatty acid concentrations cause insulin resistance associated with a defect in glucose transport or phosphorylation activity, not an impairment in glycolysis.

    “Thus, in healthy individuals, exposure to high concentrations of plasma fatty acids caused insulin resistance associated with an induced defect in either glucose transport or phosphorylation activity, not an impairment in glycolysis.”

    From Lipid-induced insulin resistance: unravelling the mechanism (2010) · cites this paper as [17]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 30 · Cited by 1,539

Research works printed but not linked: 1

  1. Chen, W., T.B. Price, D.L. Rothman, J.R. Chase, G. Bloch, G.I. Shul- man, and R.G. Shulman. 1994. Determination of G6P and glycogen changes of human muscle following exercise by interleaved 31P and 13C NMR spectros- copy. Proc. Soc. Mag. Res. 1:160.

Authors
Roden, M., Price, T. B., Perseghin, G., Petersen, K. F., Rothman, D. L., Cline, G. W., & Shulman, G. I.
Affiliations
Yale University (US)
Corresponding author
Shulman, G I
Venue
Journal of Clinical Investigation
Published
1996-06-15
Volume
97
Issue
12
Pages
2859-2865
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2059842910
Cited by
1,539
References
30
Citations by year
2026: 19 · 2025: 25 · 2024: 30 · 2023: 38 · 2022: 39 · 2021: 45 · 2020: 51 · 2019: 54 · 2018: 55 · 2017: 55 · 2016: 56 · 2015: 65 · 2014: 61 · 2013: 66 · 2012: 62
FWCI
7.07
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • BOA (University of Milano-Bicocca) (submittedVersion)
Funders
  • American Diabetes Association (DK-49230)
  • Yale University
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK45735, R01DK049230, R01DK040936, R01 DK-49230, P30DK045735)
  • National Center for Research Resources (M01RR000125, M01 RR-00125)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
Keywords
free fatty acids, insulin resistance, skeletal muscle, glucose-6-phosphate, muscle glycogen synthesis, glucose uptake, lipid oxidation, glucose oxidation, glucose transport, hyperinsulinemic-euglycemic clamp, lipid infusion, pyruvate dehydrogenase
MeSH terms
Adult, Fatty Acids, Nonesterified, Female, Glucose, Glycogen, Humans, Insulin Resistance, Male, Middle Aged, Muscle, Skeletal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review